Fernwood Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-32,259
| Closed | -$59.7K | – | 197 |
|
|
2023
Q1 | $59.7K | Hold |
32,259
| – | – | 0.02% | 180 |
|
|
2022
Q4 | $35.8K | Hold |
32,259
| – | – | 0.01% | 178 |
|
|
2022
Q3 | $75K | Hold |
32,259
| – | – | 0.03% | 179 |
|
|
2022
Q2 | $98K | Hold |
32,259
| – | – | 0.04% | 176 |
|
|
2022
Q1 | $219K | Buy |
32,259
+5,677
| +21% | +$38.5K | 0.08% | 180 |
|
|
2021
Q4 | $222K | Sell |
26,582
-102
| -0.4% | -$852 | 0.07% | 191 |
|
|
2021
Q3 | $198K | Buy |
26,684
+7,463
| +39% | +$55.4K | 0.07% | 194 |
|
|
2021
Q2 | $131K | Buy |
19,221
+6,377
| +50% | +$43.5K | 0.04% | 195 |
|
|
2021
Q1 | $132K | Buy |
+12,844
| New | +$132K | 0.05% | 186 |
|